
    
      This is a prospective, randomized study to determine the efficacy of the BRIDGE device in
      reducing pain and opioid use in patients following liver transplantation. Subjects will be
      randomized in a 1:1 ration to one of the below groups:

      Group 1: BRIDGE device will be placed prior to start of the surgery with standard of care
      pain control analgesia

      Group 2: Subjects will receive the standard of care pain control analgesia
    
  